2024-11-08T10:06:59-05:00 2023-12-31 462108854 KENDALL PREBOLA AND JONES LLC PO BOX 259 BEDFORD PA 155220259 990 2023-01-01 273492063 PROJECT PURPLE INC PROJ 2037146052 115 MAIN STREET SUITE 1 SEYMOUR CT 06483 SANDINO VERRELLI FOUNDER AND CEO 2037146052 2024-11-07 true false RICHARD M JONES CPA P00621721 8146231880 2024-11-07 X 2023 2024-10-15 13:58:12Z SANDINO VERRELLI 115 MAIN STREET SUITE 1 SEYMOUR CT 06483 2621442 false X WWW.PROJECTPURPLE.ORG X 2010 CT THE MISSION OF PROJECT PURPLE IS TO RAISE AWARENESS AND FUNDS TOWARD A CURE OF PANCREATIC CANCER. IN ADDITION, PROJECT PURPLE MOTIVATES PEOPLE TO RUN IN WORLD RENOWNED MARATHONS AND HALF MARATHONS TO RAISE MISSION CRITICAL FUNDS. 9 8 15 60 0 1729998 2489274 31579 34911 5874 27440 -2398 4819 1765053 2556444 342977 700866 0 452920 626674 0 103567 624581 780814 1420478 2108354 344575 448090 1495812 1944886 87657 88641 1408155 1856245 X THE MISSION OF PROJECT PURPLE IS TO RAISE AWARENESS AND FUNDS TOWARD A CURE OF PANCREATIC CANCER. IN ADDITION, PROJECT PURPLE MOTIVATES PEOPLE TO RUN IN WORLD RENOWNED MARATHONS AND HALF MARATHONS TO RAISE MISSION CRITICAL FUNDS. false false 1127074 5950 34911 PROGRAM AND MARATHON ACTIVITIES OUR PRIMARY FUNDRAISING COMES FROM PARTICIPATING IN MARATHONS, HALF MARATHONS, AND 5K RACES ACROSS THE COUNTRY; INCLUDING THE TOP FOUR U.S. MARATHONS. OUR TEAM CONSISTS OF RUNNERS FROM ALL OVER THE WORLD, MOST OF THEM HAVE BEEN TOUCHED BY PANCREATIC CANCER. 719067 694916 RESEARCH, SCHOLARSHIPS AND PATIENT AID PROJECT PURPLE HAS BECOME A LEADING PROVIDER OF FINANCIAL AID TO FAMILIES BATTLING PANCREATIC CANCER. WE OFFER GRANTS TO FAMILIES THAT ARE BATTLING THIS DISEASE FROM ALL OVER THE UNITED STATES. WE OFFER FINANCIAL ASSISTANCE WITH HOUSING, UTILITIES, MEDICAL, AND WE ALSO HAVE A MISCELLANEOUS CATEGORY THAT HAS BEEN USED TO COVER THINGS LIKE GAS, ALTERNATIVE LODGING, AND ANYTHING NOT COVERED IN THE OTHER CATEGORIES. PATIENTS ARE ELIGIBLE TO APPLY ONCE EVERY 12 MONTHS AND OUR TYPICAL CYCLE LASTS ANYWHERE FROM 3-4 WEEKS, DEPENDING ON THE APPLICATION, IF ALL THE REQUIREMENTS ARE IN GOOD ORDER. WE REQUIRE PATIENTS TO SUBMIT PROOF OF DIAGNOSIS AND CURRENT PROTOCOL, PHOTO ID, PREVIOUS YEAR'S TAX FILING, AS WELL AS ANY BILLS THAT THEY ARE LOOKING FOR ASSISTANCE WITH. PROJECT PURPLE IS COMMITTED TO FUNDING CRITICAL RESEARCH TOWARDS A CURE AND EARLY DETECTION OF PANCREATIC CANCER. PROJECT PURPLE HAS FUNDED OVER 3,000,000 SINCE INCEPTION FOR CLINICAL AND SCIENTIFIC RESEARCH TOWARDS ITS MISSION WITH SOME OF THE TOP SCIENTISTS AND DOCTORS IN THE UNITED STATES WORKING TOWARDS THAT GOAL. OUR RESEARCH APPROACH IS TO ASSIST IN FUNDING OF THIS CRITICAL RESEARCH WITH SOME OF THE TOP SCIENTISTS AND DOCTORS IN THE UNITED STATES. THE SCOPE OF THE MANY PROJECTS HAS RANGED FROM IMMUNOLOGY, EARLY DETECTION, BASIC SCIENCE, CLINICAL TRIALS AND MUCH MORE. 1846141 true true false false false false false false false false true false false false false true true false false false false false false false true false false true true true false false false false false false false false false false false false false false false false false true 13 0 15 true false false false false false false false false false false false false false false X 9 8 false false false false false false false true true false false true true true true true true true false false CT X SANDINO VERRELLI 2037146052 115 MAIN STREET SUITE 1 SEYMOUR CT 06483 BRYAN LIVELY PRESIDENT 3.00 X X 0 0 0 BRENT SHEEHAN VICE PRESIDE 3.00 X X 0 0 0 ALEX PALIOS TREASURER 3.00 X X 0 0 0 KATHLEEN BALDUCCI SECRETARY 2.00 X X 0 0 0 TONY LUONGO DIRECTOR 1.00 X 0 0 0 BRET SCHIPPER DIRECTOR 1.00 X 0 0 0 JAY BUTH DIRECTOR 1.00 X 0 0 0 JENNIFER BECKAGE DIRECTOR 1.00 X 0 0 0 BRIAN ZELLNER - OUTGOING DIRECTOR 1.00 X 0 0 0 SANDINO VERRELLI FOUNDER AND 40.00 X X 185855 0 2341 185855 2341 1 false true false 56981 2432293 5195 2489274 EVENT REGISTRATION FEES 711300 34911 34911 34911 32515 32515 5075 -5075 -5075 -5075 50650 56981 54927 -4277 -4277 5695 797 4898 4898 8397 4199 4198 4198 2556444 29836 37334 456950 456950 243916 243916 202323 151742 40465 10116 338101 268016 48749 21336 45604 35175 7108 3321 40646 31796 6545 2305 21456 21456 30263 28263 2000 133005 133005 109673 55406 9759 44508 47147 37552 7001 2594 28169 22436 4183 1550 112626 89944 5344 17338 11591 10885 706 9065 7220 1346 499 4377 2923 1454 RACE REG. AND SUPPLIES 134078 134078 APPAREL 61525 61525 PRE/POST MARATHON EVENTS 38512 38512 RUNNER INCENTIVES 20828 20828 18499 15969 2530 2108354 1846141 158646 103567 971816 335076 350004 704000 45788 16523 32422 27544 21169 23789 42929 28493 37153 33030 5238 4123 779648 15914 21690 10532 4000 1495812 1944886 80645 88641 7012 87657 88641 X 1306618 1328210 101537 528035 1408155 1856245 1495812 1944886 448090 X false true X true false X 1417290 892914 1327970 1729998 2489274 7857446 1417290 892914 1327970 1729998 2489274 7857446 107808 7749638 1815 5874 32515 40204 7872 4494 6901 4490 8397 32154 7929804 226623 0.97730 0.99200 X PART II, LINE 10 INVENTORY SALES 23,757 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 37153 33030 4123 4123 X 2556444 2556444 2556444 2108354 2108354 2108354 SCHEDULE D, PAGE 3, PART X ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA PROVIDE CONSISTENT GUIDANCE FOR THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN PROJECT PURPLES FINANCIAL STATEMENTS AND PRESCRIBE A THRESHOLD OF MORE LIKELY THAN NOT FOR RECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. PROJECT PURPLE PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEAR ENDED DECEMBER 31, 2023, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. AS OF DECEMBER 31, 2023, THE STATUTE OF LIMITATIONS FOR TAX YEARS 2020 THROUGH 2023 REMAINS OPEN WITH THE U.S. FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH PROJECT PURPLE FILES TAX RETURNS. IT IS PROJECT PURPLES POLICY TO RECOGNIZE INTEREST AND/OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSE. AS OF DECEMBER 31, 2023, PROJECT PURPLE HAD NO ACCRUALS FOR INTEREST AND/OR PENALTIES. GOLF OUTING EVE 107631 56981 50650 15200 4320 35407 107631 56981 50650 15200 4320 35407 54927 -4277 true ARBOR RESEARCH COLLABORATIVE 370 EARHART RD ANN ARBOR MI 48105 383289521 501C3 125000 COST CANCER RESEARCH UNIVERSITY OF NEBRASKA FOUNDATION 1010 LINCOLN MALL SUITE 300 LINCOLN NE 68508 470379839 501C3 50000 COST RESEARCH GRANTS HARTFORD HOSPITAL 80 SEYMOUR STREET HARTFORD CT 06106 222672834 501C3 175000 COST CANCER RESEARCH TARGETING RESISTANCE IN CANCER COOPERATIVE 11709 BECKET STREET POTOMAC MD 20854 874750711 C3 100000 COST CANCER RESEARCH 4 PATIENT FINANCIAL AID 262 198709 COST PATIENT CARE PACKAGES 588 19375 COST BLANKETS SCHOLARSHIPS 1 25832 COST SCHEDULE I, PAGE 1, PART I, LINE 2 MONITORING OF GRANTEES OCCURS DURING AND AFTER THE GRANT. DURING THE GRANT, THE MONITORING PROCESS - IN THE FORM OF BOTH WRITTEN REPORTS AND PHONE CALLS OFFER AN OPPORTUNITY FOR THE GRANTEE TO REFLECT ON CURRENT ACTIVITIES, BEST PRACTICES AND ROOM FOR IMPROVEMENT. FOLLOWING THE GRANT'S COMPLETION, THE GRANTEE SUBMITS A FINAL REPORT THAT IS REVIEWED FOR COMPLETION OF GRANT OBJECTIVES. X X X X false false false false false false false true false SANDINO VERRELLI FOUNDER AND CEO 138766 41775 5314 2341 188196 SCHEDULE J, PAGE 1, PART I, LINE 7 BONUSES ARE PROVIDED BASED ON A PERFORMANCE REVIEW CONDUCTED BY THE BOARD OF DIRECTORS FORM 990 - ORGANIZATION'S MISSION THE MISSION OF PROJECT PURPLE IS TO RAISE AWARENESS AND FUNDS TOWARD A CURE OF PANCREATIC CANCER. IN ADDITION, PROJECT PURPLE MOTIVATES PEOPLE TO RUN IN WORLD RENOWNED MARATHONS AND HALF MARATHONS TO RAISE MISSION CRITICAL FUNDS. FORM 990, PAGE 1, PART I, LINE 6 9 OF THE VOLUNTEERS CONSIST OF BOARD MEMBERS. FORM 990, PAGE 2, PART III, LINE 4B RESEARCH, SCHOLARSHIPS AND PATIENT AID PROJECT PURPLE HAS BECOME A LEADING PROVIDER OF FINANCIAL AID TO FAMILIES BATTLING PANCREATIC CANCER. WE OFFER GRANTS TO FAMILIES THAT ARE BATTLING THIS DISEASE FROM ALL OVER THE UNITED STATES. WE OFFER FINANCIAL ASSISTANCE WITH HOUSING, UTILITIES, MEDICAL, AND WE ALSO HAVE A MISCELLANEOUS CATEGORY THAT HAS BEEN USED TO COVER THINGS LIKE GAS, ALTERNATIVE LODGING, AND ANYTHING NOT COVERED IN THE OTHER CATEGORIES. PATIENTS ARE ELIGIBLE TO APPLY ONCE EVERY 12 MONTHS AND OUR TYPICAL CYCLE LASTS ANYWHERE FROM 3-4 WEEKS, DEPENDING ON THE APPLICATION, IF ALL THE REQUIREMENTS ARE IN GOOD ORDER. WE REQUIRE PATIENTS TO SUBMIT PROOF OF DIAGNOSIS AND CURRENT PROTOCOL, PHOTO ID, PREVIOUS YEAR'S TAX FILING, AS WELL AS ANY BILLS THAT THEY ARE LOOKING FOR ASSISTANCE WITH. PROJECT PURPLE IS COMMITTED TO FUNDING CRITICAL RESEARCH TOWARDS A CURE AND EARLY DETECTION OF PANCREATIC CANCER. PROJECT PURPLE HAS FUNDED OVER 3,000,000 SINCE INCEPTION FOR CLINICAL AND SCIENTIFIC RESEARCH TOWARDS ITS MISSION WITH SOME OF THE TOP SCIENTISTS AND DOCTORS IN THE UNITED STATES WORKING TOWARDS THAT GOAL. OUR RESEARCH APPROACH IS TO ASSIST IN FUNDING OF THIS CRITICAL RESEARCH WITH SOME OF THE TOP SCIENTISTS AND DOCTORS IN THE UNITED STATES. THE SCOPE OF THE MANY PROJECTS HAS RANGED FROM IMMUNOLOGY, EARLY DETECTION, BASIC SCIENCE, CLINICAL TRIALS AND MUCH MORE. FORM 990, PAGE 6, PART VI, LINE 11B THE FOUNDER AND CEO REVIEWS THE 990 TAX RETURN UPON RECEIPT FROM THE PREPARER. ONCE THE 990 IS APPROVED INTERNALLY, THE 990 IS FORWARDED TO THE CHAIR OF THE AUDIT COMMITTEE FOR REVIEW. ONCE APPROVED BY THE COMMITTEE CHAIR, THE FOUNDER AND CEO THEN SIGNS THE RETURN. FORM 990, PAGE 6, PART VI, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS EACH PERSON: A. HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY, B. HAS READ AND UNDERSTANDS THE POLICY, C. HAS AGREED TO COMPLY WITH THE POLICY, AND D. UNDERSTANDS THE ORGANIZATION IS CHARITABLE AND IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS: AFTER DISCLOSURE OF THE POSSIBLE CONFLICT OF INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST: A. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. B. THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. C. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE ORGANIZATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION IT SHALL MAKE ITS DECISION AS WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. FORM 990, PAGE 6, PART VI, LINE 15A THE PROCESS FOR DETERMINING EMPLOYEE COMPENSATION APPLIES TO THE COMPENSATION DETERMINATION OF THE FOUNDER AND CEO OF THE ORGANIZATION. THE PROCESS INCLUDES ALL OF THESE ELEMENTS: 1) REVIEW AND APPROVAL BY THE BOARD OF DIRECTORS OF THE ORGANIZATION; 2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND 3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1) REVIEW AND APPROVAL - THE COMPENSATION OF THE FOUNDER AND CEO IS REVIEWED AND APPROVED BY AN APPOINTED SUBCOMMITTEE OF THE BOARD OF DIRECTORS OF THE ORGANIZATION. THE COMPENSATION IS THEN APPROVED BY THE ENTIRE BOARD OF DIRECTORS. ANY PERSONS WITH CONFLICT OF INTERESTS WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2) USE OF DATA AS TO COMPARABLE COMPENSATION - THE COMPENSATION OF THE FOUNDER AND CEO IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING - THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. FORM 990, PAGE 6, PART VI, LINE 19 THESE DOCUMENTS AND POLICIES ARE PROVIDED UPON REQUEST.